Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandy Joaquina

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Frontiers in Bioengineering and Biotechnology|July 6, 2023
Determination of CAR T cell metabolism in an optimized protocolSandy Joaquina, Christopher Forcados, Benjamin Caulier, et al.
Cells|May 14, 2022
How CAR T Cells BreatheChristopher Forcados, Sandy Joaquina, Nicholas Paul Casey, et al.
STAR Protocols|December 31, 2024
Protocol for production of tonic CAR T cells with dasatinibLéa Rosselle, Thibault Leray, Sandy Joaquina, et al.
Cancer Immunology Research|October 23, 2021
CAR T-cell Entry into Tumor Islets Is a Two-Step Process Dependent on IFNγ and ICAM-1Chahrazade Kantari-Mimoun, Sarah Barrin, Lene Vimeux, et al.
Cell Reports. Medicine|May 16, 2024
CD37 is a safe chimeric antigen receptor target to treat acute myeloid leukemiaBenjamin Caulier, Sandy Joaquina, Pascal Gelebart, et al.
Journal for Immunotherapy of Cancer|April 11, 2024
Efficient CAR T cell targeting of the CA125 extracellular repeat domain of MUC16Nicholas P Casey, Katrin Kleinmanns, Christopher Forcados, et al.
Nature Communications|June 8, 2023
ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcomaNadia Mensali, Hakan Köksal, Sandy Joaquina, et al.
Nature Biomedical Engineering|June 4, 2021
T cells armed with C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumoursStefanie Lesch, Viktoria Blumenberg, Stefan Stoiber, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Frontiers in Bioengineering and Biotechnology|July 6, 2023
Determination of CAR T cell metabolism in an optimized protocolSandy Joaquina, Christopher Forcados, Benjamin Caulier, et al.
Cells|May 14, 2022
How CAR T Cells BreatheChristopher Forcados, Sandy Joaquina, Nicholas Paul Casey, et al.
STAR Protocols|December 31, 2024
Protocol for production of tonic CAR T cells with dasatinibLéa Rosselle, Thibault Leray, Sandy Joaquina, et al.
Cancer Immunology Research|October 23, 2021
CAR T-cell Entry into Tumor Islets Is a Two-Step Process Dependent on IFNγ and ICAM-1Chahrazade Kantari-Mimoun, Sarah Barrin, Lene Vimeux, et al.
Cell Reports. Medicine|May 16, 2024
CD37 is a safe chimeric antigen receptor target to treat acute myeloid leukemiaBenjamin Caulier, Sandy Joaquina, Pascal Gelebart, et al.
Journal for Immunotherapy of Cancer|April 11, 2024
Efficient CAR T cell targeting of the CA125 extracellular repeat domain of MUC16Nicholas P Casey, Katrin Kleinmanns, Christopher Forcados, et al.
Nature Communications|June 8, 2023
ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcomaNadia Mensali, Hakan Köksal, Sandy Joaquina, et al.
Nature Biomedical Engineering|June 4, 2021
T cells armed with C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumoursStefanie Lesch, Viktoria Blumenberg, Stefan Stoiber, et al.
Pageof 1